Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-13-001538
Filing Date
2013-05-03
Accepted
2013-05-03 17:06:45
Documents
1
Period of Report
2013-05-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT lapenta-form4_050113.html 4  
1 OWNERSHIP DOCUMENT lapenta-form4_050113.xml 4 3701
  Complete submission text file 0001387131-13-001538.txt   5396
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Issuer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ASTON CAPITAL 177 BROAD ST., 12TH FLOOR STAMFORD CT 06901
Business Address
LaPenta Robert V Jr (Reporting) CIK: 0001543405 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-00100 | Film No.: 13813592